Guo Bin, Cheng Wei, Xu Yongjie, Zhou Xiaoyan, Li Xinmin, Ding Xiaojuan, Ding Shijia
Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Department of Clinical Laboratory, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.
Sci Rep. 2017 Oct 25;7(1):14037. doi: 10.1038/s41598-017-14361-5.
In this work, a simple and enzyme-free surface plasmon resonance (SPR) biosensing strategy has been developed for highly sensitive detection of two major PML/RARα (promyelocytic leukemia, retinoic acid receptor alpha) subtypes based on the heterogeneous fusion gene-triggered nonlinear hybridization chain reaction (HCR). On the gold chip surface, the cascade self-assembly process is triggered after the introduction of PML/RARα. The different fragments of PML/RARα can specifically hybridize with capture probes (Cp) immobilized on the chip and the hybridization DNA (H). Then, the nonlinear HCR is initiated by the complex of Cp-PML/RARα-H with the introduction of two hybridization DNA chains (H and H). As a result, a dendritic nanostructure is achieved on the surface of chip, leading to a significant SPR amplification signal owing to its high molecular weight. The developed method shows good specificity and high sensitivity with detection limit of 0.72 pM for "L" subtype and 0.65 pM for "S" subtype. Moreover, this method has been successfully applied for efficient identification of clinical positive and negative PCR samples of the PML/RARα subtype. Thus, this developed biosensing strategy presents a potential platform for analysis of fusion gene and early diagnosis of clinical disease.
在本研究中,基于异质融合基因触发的非线性杂交链式反应(HCR),开发了一种简单且无酶的表面等离子体共振(SPR)生物传感策略,用于高灵敏度检测两种主要的早幼粒细胞白血病/维甲酸受体α(PML/RARα)亚型。在金芯片表面,引入PML/RARα后触发级联自组装过程。PML/RARα的不同片段可与固定在芯片上的捕获探针(Cp)和杂交DNA(H)特异性杂交。然后,通过引入两条杂交DNA链(H和H),由Cp-PML/RARα-H复合物引发非线性HCR。结果,在芯片表面形成树枝状纳米结构,由于其高分子量导致显著的SPR放大信号。所开发的方法具有良好的特异性和高灵敏度,“L”亚型的检测限为0.72 pM,“S”亚型的检测限为0.65 pM。此外,该方法已成功应用于高效鉴定PML/RARα亚型的临床PCR阳性和阴性样本。因此,这种开发的生物传感策略为融合基因分析和临床疾病的早期诊断提供了一个潜在的平台。